A Phase III Randomized Trial of the Timing of Meloxicam With Iodine-125 Prostate Brachytherapy

International Journal of Radiation Oncology Biology Physics

Volumn 77, Issue 2, 2010, Pages 496-501

  Crook, Juanita ^a   Patil, Nikhilesh ^a   Wallace, Kris ^a   Borg, Jette ^a   Zhou, David ^a   Ma, Clement ^a   Pond, Greg ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

Acute urinary retention; COX 2 inhibitors; Postimplant edema; Prostate brachytherapy

Indexed keywords

ANTI-INFLAMMATORIES; BRACHYTHERAPY; COX-2 INHIBITORS; CYCLOOXYGENASE 2; EDEMA FACTORS; FLUOROSCOPIC GUIDANCE; INFLAMMATORY RESPONSE; INTERNATIONAL PROSTATE SYMPTOM SCORES; IODINE-125; MELOXICAM; MR IMAGING; POSTIMPLANT EDEMA; PROSTATE BRACHYTHERAPY; PROSTATE VOLUME; RANDOMIZED TRIAL; RETENTION RATE; TRANSRECTAL ULTRASOUND; URINARY RETENTION; URINARY SYMPTOMS;

INDUSTRIAL CHEMICALS; IODINE; MAGNETIC RESONANCE IMAGING; ONCOLOGY;

RADIOTHERAPY;

IODINE 125; MELOXICAM; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER RADIOTHERAPY; CATHETERIZATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSIMETRY; DRUG EFFICACY; DRUG SAFETY; FLUOROSCOPY; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE DISEASE; PROSTATE EDEMA; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; TRANSRECTAL ULTRASONOGRAPHY; TUMOR VOLUME; URINE RETENTION;

ADMINISTRATION, ORAL; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BRACHYTHERAPY; CYCLOOXYGENASE 2 INHIBITORS; DRUG ADMINISTRATION SCHEDULE; EDEMA; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; ONTARIO; PROSTATIC DISEASES; THIAZINES; THIAZOLES; URINARY RETENTION;

EID: 77951937434     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.04.078     Document Type: Article

References (36)

1. Potters L., Morgenstern C., Calugaru E., et al. 12-year outcomes following permanent prostate brachytherapy in patients with clinically localized prostate cancer. J Urol 179 (2008) S20-S24
2. Blasko J.C., Mate T., Sylvester J.E., et al. Brachytherapy for carcinoma of the prostate: Techniques, patient selection, and clinical outcomes. Semin Radiat Oncol 12 (2002) 81-94
3. Feigenberg S.J., Wolk K.L., Yang C.H., et al. Celecoxib to decrease urinary retention associated with prostate brachytherapy. Brachytherapy 2 (2003) 103-107
4. Issioui T., Klein K.W., White P.F., et al. The efficacy of premedication with celecoxib and acetaminophen in preventing pain after otolaryngologic surgery. Anesth Analg 94 (2002) 1188
5. Reuben S.S., Bhopatkar S., Maciolek H., et al. The preemptive analgesic effect of rofecoxib after ambulatory arthroscopic knee surgery. Anesth Analg 94 (2002) 55
6. Roelofs P.D., Deyo R.A., Koes B.W., et al. Nonsteroidal anti-inflammatory drugs for low back pain: An updated Cochrane review. Spine 33 (2008) 1766-1774
7. Merrick G.S., Butler W.M., Dorsey A.T., et al. Influence of prophylactic dexamethasone on edema following prostate brachytherapy. Tech Urol 6 (2000) 117-122
8. Crook J., McLean M., Yeung I., et al. MRI-CT fusion to assess post brachytherapy prostate volume and the effects of prolonged edema on dosimetry following trans-perineal interstitial permanent prostate brachytherapy. Brachytherapy 3 (2004) 55-60
9. Crook J., Milosevic M., Catton P., et al. Interobserver variation in post-implant computed tomography contouring affects quality assessment of prostate brachytherapy. Brachytherapy 1 (2002) 66-73
10. Nath R., Anderson L.L., Luxton G., et al. for the American Association of Physicists in Medicine. Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM radiation therapy committee task group no. 43. Med Phys 22 (1995) 209-234
11. Crook J.M., Potters L., Stock R.G., et al. Critical organ dosimetry in permanent seed prostate brachytherapy: Defining the organs at risk. Brachytherapy 4 (2005) 186-194
12. Nag S., Bice W., DeWyngaert K., et al. The American Brachytherapy Society recommendations for permanent prostate brachytherapy post-implant dosimetric analysis. Int J Radiat Oncol Biol Phys 46 (2000) 221-230
13. Crook J., McLean M., Catton C., et al. Factors influencing risk of acute urinary retention after TRUS-guided permanent prostate seed implantation. Int J Radiat Oncol Biol Phys 52 (2002) 453-460
14. Wyler S.F., Engeler D.S., Seelentag W., et al. Health-related quality of life after radical prostatectomy and low-dose-rate brachytherapy for localized prostate cancer. Urol Int 82 (2009) 17-23
15. Taussky D., Liu A., Abrahamowicz M., et al. Factors influencing treatment decisions in patients with low risk prostate cancer referred to a brachytherapy clinic. Can J Urol 15 (2008) 4415-4420
16. Voulgaris S., Nobes J.P., Laing R.W., et al. State-of-the-art: Prostate LDR brachytherapy. Prostate Cancer Prostatic Dis 11 (2008) 237-240
17. Ferrer M., Suarez J.F., Guedea F., et al. Health-related quality of life 2 years after treatment with radical prostatectomy, prostate brachytherapy, or external beam radiotherapy in patients with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 72 (2008) 421-432
18. Dandapani S.V., and Sanda M.G. Measuring health-related quality of life consequences from primary treatment for early-stage prostate cancer. Semin Radiat Oncol 18 (2008) 67-72
19. Frank S.J., Pisters L.L., Davis J., et al. An assessment of quality of life following radical prostatectomy, high dose external beam radiation therapy and brachytherapy iodine implantation as monotherapies for localized prostate cancer. J Urol 177 (2007) 2151-2156
20. Dalkin B.L., Christopher B.A., and Shawler D. Health-related quality of life outcomes after radical prostatectomy: Attention to study design and the patient-based importance of single-surgeon studies. Urol Oncol 24 (2006) 28-32
21. Goeman L., Salomon L., La De Taille A., et al. Long-term functional and oncological results after retroperitoneal laparoscopic prostatectomy according to a prospective evaluation of 550 patients. World J Urol 24 (2006) 281-288
22. Lein M., Stibane I., Mansour R., et al. Complications, urinary continence, and oncologic outcome of 1000 laparoscopic transperitoneal radical prostatectomies-experience at the Charite Hospital Berlin, Campus Mitte. Eur Urol 50 (2006) 1278-1274
23. Merrick G.S., Butler W.M., Lief J.H., et al. Temporal resolution of urinary morbidity following prostate brachytherapy. Int J Radiat Oncol Biol Phys 47 (2000) 121-128
24. 125I prostate brachytherapy. Brachytherapy 5 (2006) 9-13
25. Keyes M., Miller S., Moravan V., et al. Predictive factors for acute and late urinary toxicity after permanent prostate brachytherapy: Long-term outcome in 712 consecutive patients. Int J Radiat Oncol Biol Phys (2008)
26. Kelly K., Swindell R., Routledge J., et al. Prediction of urinary symptoms after 125 iodine prostate brachytherapy. Clin Oncol (R coll Radiol) 18 (2006) 326-332
27. Locke J., Ellis W., Wallner K., et al. Risk factors for acute urinary retention requiring temporary intermittent catheterization after prostate brachytherapy: A prospective study. Int J Radiat Oncol Biol Phys 52 (2002) 712-719
28. Henderson A., Cahill D., Laing R.W., et al. (125) iodine prostate brachytherapy: Outcome from the first 100 consecutive patients and selection strategies incorporating urodynamics. BJU Int 90 (2002) 567-572
29. Lee N., Wuu C.S., Brody R., et al. Factors predicting for post implantation urinary retention after permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys 48 (2000) 1457-1460
30. Keyes M., Schellenberg D., Moravan V., et al. Decline in urinary retention incidence in 805 patients after prostate brachytherapy: The effect of a learning curve?. Int J Radiat Oncol Biol Phys 64 (2006) 825-834
31. Buskirk S.J., Pinkstaff D.M., Petrou S.P., et al. Acute urinary retention after transperineal template-guided prostate biopsy. Int J Radiat Oncol Biol Phys 59 (2004) 1360-1366
32. Bucci J., Morris W.J., Keyes M., et al. Predictive factors of urinary retention following prostate brachytherapy. Int J Radiat Oncol Biol Phys 53 (2002) 91-98
33. Terk M.D., Stock R.G., and Stone N.N. Identification of patients at increased risk for prolonged urinary retention following radioactive seed implantation of the prostate. J Urol 160 (1998) 1379-1382
34. Jeong C.W., Park H.R., Hong S.K., et al. Comparison of prostate volume measured by transrectal ultrasonography and MRI with the actual prostate volume measured after radical prostatectomy. Urol Int 81 2 (2008) 79-85
35. McLaughlin P.W., Narayana V., Jackson T.R., et al. The impact of MRI training on improvement of CT-based post implant dosimetry: A six physician study. [Abstract]. Int J Radiat Oncol Biol Phys 63(Suppl1 (2005) S327-S328
36. Valicenti R.K., Sweet J.W., Hauck W.W., et al. Variation of clinical target volume definition in three-dimensional conformal radiation therapy for prostate cancer. Int J Radiat Oncol Biol Phys 44 (1999) 931-935